bf/NASDAQ:NBIX_icon.jpeg

COM:NEUROCRINE

Neurocrine Biosciences

  • Stock

Last Close

123.98

08/11 21:00

Market Cap

14.81B

Beta: -

Volume Today

532.92K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
2.92M
-
19.77M
-
15M
24.12%
161.63M
977.51%
451.24M
179.19%
788.10M
74.65%
1.05B
32.71%
1.13B
8.38%
1.49B
31.34%
1.89B
26.76%
cost of revenue
1.25M
-
4.89M
289.87%
7.40M
51.36%
10.10M
36.49%
14.30M
41.58%
23.20M
62.24%
39.70M
71.12%
gross profit
2.92M
-
19.77M
-
15M
24.12%
160.37M
969.15%
446.35M
178.32%
780.70M
74.91%
1.04B
32.68%
1.12B
8.05%
1.47B
30.94%
1.85B
26.06%
selling and marketing expenses
general and administrative expenses
13.35M
-
17.99M
34.74%
32.48M
80.58%
68.08M
109.61%
169.91M
149.56%
248.93M
46.51%
selling general and administrative expenses
13.35M
-
17.99M
34.74%
32.48M
80.58%
68.08M
109.61%
169.91M
149.56%
248.93M
46.51%
354.10M
42.25%
433.30M
22.37%
583.30M
34.62%
752.70M
29.04%
887.60M
17.92%
research and development expenses
39.25M
-
46.42M
18.29%
81.49M
75.53%
94.29M
15.71%
121.83M
29.20%
160.52M
31.76%
200M
24.59%
275M
37.50%
328.10M
19.31%
463.80M
41.36%
565M
21.82%
other expenses
16K
-
18K
12.50%
11K
38.89%
13K
18.18%
-20K
253.85%
154.27M
-
164.50M
6.63%
105.30M
35.99%
143.90M
-
cost and expenses
52.60M
-
64.41M
22.46%
113.97M
76.94%
162.37M
42.47%
292.99M
80.44%
414.35M
41.42%
561.50M
35.52%
718.40M
27.94%
925.70M
28.86%
1.24B
33.92%
1.49B
20.38%
operating expenses
52.60M
-
64.41M
22.46%
113.97M
76.94%
162.37M
42.47%
291.73M
79.67%
409.46M
40.35%
554.10M
35.33%
708.30M
27.83%
911.40M
28.67%
1.22B
33.48%
1.45B
19.41%
interest expense
19.52M
-
30.53M
56.38%
32M
4.81%
32.80M
2.50%
25.80M
21.34%
7.10M
72.48%
4.60M
35.21%
ebitda
-53.25M
-
-68.26M
28.19%
-99.46M
45.71%
-153.64M
54.47%
-131.38M
14.49%
36.90M
128.08%
226.60M
514.18%
327.50M
44.53%
207.80M
36.55%
249M
19.83%
416.10M
67.11%
operating income
-49.68M
-
-64.41M
29.66%
-94.20M
46.25%
-147.37M
56.44%
-131.36M
10.86%
36.90M
128.09%
219.15M
493.98%
318.90M
45.52%
196.90M
38.26%
249M
26.46%
250.90M
0.76%
depreciation and amortization
671K
-
827K
23.25%
1.01M
22.01%
1.45M
44.00%
2.40M
65.18%
4.02M
67.67%
7.45M
85.19%
8.60M
15.41%
10.90M
26.74%
15.60M
43.12%
21.30M
36.54%
total other income expenses net
3.59M
-
3.87M
7.83%
5.27M
36.29%
6.28M
19.14%
8.34M
32.79%
15.48M
85.52%
-172.65M
1,215.59%
-212.20M
22.91%
-95.50M
55.00%
-35.10M
63.25%
-58.10M
65.53%
income before tax
-46.09M
-
-60.54M
31.36%
-88.93M
46.89%
-141.09M
58.65%
-142.54M
1.03%
21.84M
115.32%
46.50M
112.90%
106.70M
129.46%
101.40M
4.97%
213.90M
110.95%
332.10M
55.26%
income tax expense
-4.24M
-
-4.68M
10.25%
-6.27M
34.05%
-7.72M
23.14%
17.10M
321.48%
730K
95.73%
9.50M
1,201.37%
-300.60M
3,264.21%
11.80M
103.93%
59.40M
403.39%
82.40M
38.72%
net income
-46.09M
-
-60.54M
31.36%
-88.93M
46.89%
-141.09M
58.65%
-142.54M
1.03%
21.11M
114.81%
37M
75.26%
407.30M
1,000.81%
89.60M
78.00%
154.50M
72.43%
249.70M
61.62%
weighted average shs out
66.80M
-
74.58M
11.65%
84.50M
13.30%
86.56M
2.44%
87.99M
1.65%
95.40M
8.42%
91.63M
3.95%
93.10M
1.61%
94.60M
1.61%
95.80M
1.27%
97.70M
1.98%
weighted average shs out dil
66.99M
-
74.58M
11.33%
84.50M
13.30%
86.71M
2.62%
88.09M
1.59%
95.40M
8.30%
95.73M
0.35%
97.80M
2.16%
97.90M
0.10%
98.90M
1.02%
101M
2.12%
eps
-0.69
-
-0.81
17.39%
-1.05
29.63%
-1.63
55.24%
-1.62
0.61%
0.22
113.58%
0.40
81.82%
4.37
992.50%
0.95
78.26%
1.61
69.47%
2.56
59.01%
epsdiluted
-0.69
-
-0.81
17.39%
-1.05
29.63%
-1.63
55.24%
-1.62
0.61%
0.22
113.58%
0.39
77.27%
4.16
966.67%
0.92
77.88%
1.56
69.57%
2.47
58.33%

All numbers in (except ratios and percentages)